Castle Biosciences CSTL
NASDAQ CSTL
$35.35 +0.36 (+1.03%)
As of: Sep 22, 2026 · 10:04 AM EDT

Castle Biosciences (CSTL) Non Operating Interest Expenses (2018 - 2026)

Castle Biosciences' (CSTL) quarterly Non Operating Interest Expenses came in at $193000.0 in Q2 2026, up 819.05% year-over-year from $21000.0 in Q2 2025, and up 44.03% quarter-over-quarter from $134000.0 in Q1 2026.

Analysis

Castle Biosciences (CSTL) Non Operating Interest Expenses (2018 - 2026) Analysis & Trends

Castle Biosciences has disclosed Non Operating Interest Expenses across 9 years of filings, most recently posting $193000.0 for Q2 2026.

  • In Q2 2026, Non Operating Interest Expenses rose 819.05% year-over-year to $193000.0; the TTM figure through Jun 2026 stood at $375000.0 (up 13.29% YoY), while the FY2025 annual figure was $86000.0, down 85.1% from the prior year.
  • Non Operating Interest Expenses came in at $193000.0 for Q2 2026 at Castle Biosciences, up from $134000.0 in the prior quarter.
  • In the past five years, Non Operating Interest Expenses ranged from a high of $270000.0 in Q2 2024 to a low of $2000.0 in Q3 2023.
  • Average Non Operating Interest Expenses over 5 years is $56555.6, with a median of $15500.0 recorded in 2024.
  • Year-over-year, Non Operating Interest Expenses soared 9950.0% in 2024 and plunged 92.22% in 2025.
  • Over 5 years, Non Operating Interest Expenses stood at $4000.0 in 2022, then plunged by 50.0% to $2000.0 in 2023, then surged by 4500.0% to $92000.0 in 2024, then plunged by 73.91% to $24000.0 in 2025, then surged by 704.17% to $193000.0 in 2026.
  • Per Business Quant data, the three most recent Non Operating Interest Expenses figures were $193000.0 in Q2 2026, $134000.0 in Q1 2026, and $24000.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Natera 53.05 Bn 51.95 Bn 486.15 Mn 890,000.00
2 Quest Diagnostics 27.19 Bn 26.87 Bn 1.03 Bn -
3 Labcorp Holdings 25.93 Bn 25.81 Bn 1.11 Bn 61.10 Mn
4 Guardant Health 23.97 Bn 22.91 Bn 219.03 Mn 1.35 Mn
5 Tempus AI 13.64 Bn 12.82 Bn 274.25 Mn 10.28 Mn
6 Caris Life Sciences 8.47 Bn 7.68 Bn 182.38 Mn 9.23 Mn
7 Sotera Health 5.35 Bn 4.99 Bn 177.96 Mn -
8 BillionToOne 4.96 Bn 4.41 Bn 77.11 Mn 8,000.00
9 Adaptive Biotechnologies 4.55 Bn 4.21 Bn 51.39 Mn 2.69 Mn
10 Castle Biosciences 1.08 Bn 811.36 Mn 79.85 Mn 193,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 193,000.00
Mar 31, 2026 134,000.00
Dec 31, 2025 24,000.00
Sep 30, 2025 24,000.00
Jun 30, 2025 21,000.00
Mar 31, 2025 17,000.00
Dec 31, 2024 92,000.00
Sep 30, 2024 201,000.00
Jun 30, 2024 270,000.00
Mar 31, 2024 14,000.00
Dec 31, 2023 2,000.00
Sep 30, 2023 2,000.00
Jun 30, 2023 3,000.00
Mar 31, 2023 4,000.00
Dec 31, 2022 4,000.00
Sep 30, 2022 6,000.00
Jun 30, 2022 4,000.00
Mar 31, 2022 3,000.00
Dec 31, 2021 1,000.00
Dec 31, 2020 395,000.00
API Access

Castle Biosciences Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=CSTL&period=max&api_key=YOUR_API_KEY